Daiichi Sankyo
Daiichi Sankyo chief executive elected NPC chairman of the Board
November 19, 2012Manufacturing and Production, Research and Development, Sales and Marketing Daiichi Sankyo
The National Pharmaceutical Council (NPC) has announced that Daiichi Sankyo president and chief executive John Gargiulo has been elected chairman …
Daiichi Sankyo: breaking down barriers with social media
August 1, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chatter, Daiichi Sankyo, NHS, social media
Digital media is known to help create interaction and dialogue between groups and organisations, but new technology can also create …
New chief executive for Daiichi Sankyo Europe
July 10, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daiichi Sankyo
Jan Van Ruymbeke has been appointed as the new chief executive of Daiichi Sankyo Europe from October. Van Ruymbeke, from Belgium, …
Microsoft buys Yammer for $1.2 billion
June 28, 2012Medical Communications Daiichi Sankyo, Facebook, Microsoft, Yammer, social network
Microsoft has acquired Yammer, an internal social networking system for businesses, for $1.2 billion. Set up in 2008, Yammer closely …
Daiichi Sankyo subsidiary gets FDA warning
September 15, 2011Daiichi Sankyo, FDA, Luitpold
Daiichi Sankyo’s US subsidiary Luitpold Pharmaceuticals has been sent a warning letter by the FDA for “significant” and repeated quality …
Daiichi Sankyo: Europe poses huge challenge for pharma
June 9, 2011Research and Development, Sales and Marketing Cancer, Daiichi Sankyo, pricing
Japanese pharma company Daiichi Sankyo is expanding its European operations, creating a new oncology business unit. But outlining its plans …
Japan’s pharma industry pledges to maintain medicines supply
March 17, 2011Sales and Marketing Astellas, Boehringer Ingelheim, Daiichi Sankyo, Eisai, Japan, earthquake
Pharmaceutical firms in Japan have escaped the very worst of the devastation caused by the earthquake and tsunami, and have …
Daiichi recalls contaminated paediatric vaccines
March 15, 2011Manufacturing and Production ActHIB, Daiichi Sankyo, manufacturing compliance, padiatric vaccine recall, recalls, vaccines
Japanese drugmaker Daiichi Sankyo has recalled around 1.3 million doses of the paediatric vaccine ActHIB, manufactured by Sanofi-Aventis, because of …
Daiichi Sankyo gains rights to potential blockbuster cancer drug
March 2, 2011Research and Development BRAF protein, Daiichi Sankyo, PLX4032, Plexxikon, melanoma, personalised medicine
Daiichi Sankyo has purchased US-based discovery firm Plexxikon for $805 million, gaining access to its potential blockbuster melanoma drug PLX4032. …
Daiichi-Sankyo cleared of rep misconduct
November 22, 2010Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Daiichi Sankyo, Daiichi-Sankyo, Olmetec, PMCPA, olmesartan, pharma sales representative
Daiichi-Sankyo has been cleared of any wrongdoing in relation to the ABPI Code after one of its representatives was accused …
Ranbaxy chief executive steps down
August 13, 2010Medical Communications, Sales and Marketing Daiichi Sankyo, Ranbaxy
The chief executive of Ranbaxy Mr Atul Sobti is to step down after an apparent a rift with the company’s …
Abbott and Daiichi Sankyo acclaimed in great places to work survey
May 31, 2010Business Services Abbott, Daiichi Sankyo
The Great Place to Work Institute has named Abbott as one of the Top 50 Best Workplaces in the UK, …
Dr Jay Feingold joins Daiichi Sankyo
February 19, 2010Research and Development Daiichi Sankyo, appointment, research and development
Daiichi Sankyo’s US arm has appointed Dr Jay Feingold vice president of medical affairs. In this role his will manage …
Effient approved in US
July 17, 2009Research and Development, Sales and Marketing Daiichi Sankyo, Effient, US, lilly
Lilly and Daaichi-Sankyo have gained US approval of their new blood clotting treatment Effient, but hopes of strong sales are …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
